VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon May 11, 2024 6:15am

93 Views

Post# 36035015

VMS+ workshops which provided a window to the future of echo

As AEPC 2024 draws to a close I would like to thank our Ventripoint team members and distribution partners Angiopro and Cardiologic for all of their hard work preparing for, and participating in this years annual meeting. This years meeting saw a record number of registrants in attendance which speaks to the importance of this forum.

Thanks also go out to all of those delegates who visited our booth and attended the VMS+ workshops which provided a window to the future of echo AI.

#AEPC2024 #PediatricCardiology #Angiopro #Ventripoint #Cardiologic